SEARCH RESULTS

329939 RESULTS

MAPT G200E

MUTATIONS MAPT 44060769 GRCh37/hg19 rs757159453 G A Exon 4a Point, Missense Coding Unknown; predicted possibly damaging in silico. Not applicable. G200E Frontotemporal Dementia: BenignNone This variant in MAPT was found in an exome sequencing study of 141 Caucasian

Neural Circuitry Goes Haywire in Both Sporadic and Familial AD

RESEARCH NEWS 2014-08-15 Research News Neural circuits falter in the earliest stages of Alzheimer’s Disease, regardless of when or why it strikes, according to a paper in the July 28 JAMA Neurology. A large cadre of researchers led by Beau Ances at Washington University in St. Lo

APP K496Q

MUTATIONS APP 27328042 GRCh37/hg19 rs201384815 A C Exon 12 Point, Missense Coding In cells, slight increase in Aβ40, but Aβ42/Aβ40 ratio not significantly different from controls. One reported carrier of this variant had autopsy-confirmed AD. K496Q Alzheimer's

MAPT G213R

MUTATIONS MAPT 44060807 GRCh37/hg19 rs76375268 G A Exon 4a Point, Missense Coding Unknown; predicted possibly damaging in silico. Unknown. G213R Frontotemporal Dementia: Benign, Alzheimer's Disease: Unclear PathogenicityAlzheimer's Disease This variant wa

APP A201V

MUTATIONS APP 27423376 GRCh37/hg19 rs149995579 C T Exon 5 Point, Missense Coding In cells, no effect on Aβ42, Aβ40, and Aβ42/Aβ40. Not applicable. A201V Alzheimer's Disease: Benign, Parkinson's Disease Dementia: Not ClassifiedNone, Parkinson's Diseas

MAPT V224G

MUTATIONS MAPT 44060841 GRCh37/hg19 rs141120474 T G Exon 4a Point, Missense Coding Unknown; predicted possibly damaging in silico. Unknown. V224G Frontotemporal Dementia: Benign, Alzheimer's Disease: Unclear PathogenicityAlzheimer's Disease, None This var

APP E599K

MUTATIONS APP 27284167 GRCh37/hg19 rs140304729 G A Exon 14 Point, Missense Coding In cells, reduced Aβ40 secretion, but did not significantly alter Aβ42 secretion nor the Aβ42/Aβ40 ratio. Not applicable. E599K Alzheimer's Disease: Benign, Parkinson's Dise

Therapies Take Aim at Tau

CONFERENCE COVERAGE 2014-08-15 Conference Coverage Researchers continue to target tau in hopes of treating patients with Alzheimer’s or other tauopathies. At the Alzheimer’s Association International Conference 2014 held July 12-17 in Copenhagen, Denmark, scientists presented their lat

Maria Joseph


Max-Planck institute for neurological disease
Bonn, Germany

Blocking Glial Receptor Protects Motor Neurons in Culture and Mice

RESEARCH NEWS 2014-08-14 Research News Neuron-supporting glial cells can rebel in amyotrophic lateral sclerosis, turning against the very motor neurons they are supposed to nurse. Blocking the microglial prostanoid receptor DP1 alleviates this toxicity, according to a paper in th

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE